Followers | 30 |
Posts | 3402 |
Boards Moderated | 0 |
Alias Born | 07/25/2016 |
Sunday, June 25, 2017 7:21:23 AM
Because NES is not an "investment hedge fund." It's one of the largest property escrow and 1031 exchange institutions in the world. They acquired JP Morgan's 1031 exchange subsidiary a few years back. NES is a cash cow. Last public info is that they did 85 BILLION of transactions back in 2014. Considering how those companies invest, would figure about 4-5% of those transactions went to NES as fees and portfolio income. Steipp is probably making a minimum of 3-4 mill per year, he can sit back and do mostly nothing as their platform does all the work, and from filings, they may be angling to go public. Nice work, if you can get it, "in retirement." I'm sure he was angling for this job, as a board member, for quite a while. Yes, anyone would be lying if they said they weren't jealous or envious how he positioned himself.
That's why he didn't "go to work in the BMG business" and is he comparable to Lugee in terms of BMG knowledge and business experience? Hell, no. He was pushed out, but he was smart to get out when he did. Steipp is irrelevant to LQMT going forward, but he certainly maneuvered himself well, always has. Diluted a lot of shares and spent a TON of money, but they were always on the balls of their ass. Never put blind faith in a public company exec as they always hide behind "SEC confidentiality."
Chung was given a power of attorney. He has a blank check and full authorization to sign off on Lugee's behalf. It's public info that his name and signature are on the contract for the 8 million dollar building, but "he won't be around much longer"? Where are all the "great financial people" under Lugee's employ? What are their names? Haven't seen that public anywhere. Would be helpful to see them named.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM